Skip to main content

Table 1 Baseline characteristics among women treated for PPH

From: Misoprostol in addition to routine treatment of postpartum hemorrhage: A hospital-based randomized-controlled trial in Karachi, Pakistan

 

misoprostol

placebo

 
 

n = 29

n = 32

RR [95% CI] or p-value

Age (years) mean ± sd

25 ± 5

26 ± 4

p = .291

Parity %(n)

   

   0

62.1 (18)

40.6 (13)

1.53 [.92, 2.54]

   1–3

31.0 (9)

50.0 (16)

 

   4–8

6.9 (2)

9.4 (3)

 

Outcome of this delivery %(n)

   

   Singleton, alive

93.1 (27)

96.9 (31)

.96 [.85, 1.08]

   Singleton, still birth

3.4 (1)

--

 

   Twins, both alive

3.4 (1)

3.7 (1)

 

Episiotomy %(n)

75.9 (22)

68.8 (22)

1.10 [.81, 1.51]

Manual removal of placenta done %(n)

6.9 (2)

12.5 (4)

.55 [.11, 2.79]

Placental delivery within 5 minutes %(n)

62.1 (18)

78.1 (25)

.79 [.57,1.11]

Pre-delivery hemoglobin (g/dL)

   

   mean ± sd

11.1 ± 1.0

10.9 ± 1.1

p = .502

   range

9.1 – 13.5

8.7 – 13.0

 

Measured blood loss at diagnosis (ml)

   

   mean ± sd

640 ± 139

669 ± 184^

p = .492

   range

400 – 1000

500 – 1000

 

Time to diagnosis (minutes)

   

   mean ± sd

37 ± 29

33 ± 24

p = .584

   range

5 – 122

5 – 100

 

Use of oxytocics prior to study treatment %(n)

100 (29)

100 (32)

1.0

Use of oxytocics after study treatment %(n)

100 (29)

100 (32)

1.0

  1. ^ There is one outlier excluded in which the woman was diagnosed after losing 1,750 ml.